The Natural History of Trisomy 21: Outcome Data from a Large Tertiary Referral Centre

Abstract

<b><i>Objective:</i></b> The aim of the study was to prospectively gather data on pregnancy outcomes of prenatally diagnosed trisomy 21 (T21) in a large tertiary referral centre. <b><i>Methods:</i></b> Data were gathered prospectively in a large tertiary referral centre over 5 years from 2013 to 2017 inclusively. Baseline demographic and pregnancy outcome data were recorded on an anonymized computerized database. <b><i>Results:</i></b> There were 1,836 congenital anomalies diagnosed in the study period including 8.9% (<i>n</i> = 165) cases of T21. 79% (<i>n</i> = 131) were age 35 or older at diagnosis. 79/113 (69.9%) women chose a termination of pregnancy (TOP) following a diagnosis of T21. Amongst pregnancies that continued, there were 4 second-trimester miscarriages (4/34, 11.7%), 9 stillbirths (9/34, 26.4%), and 1 neonatal death, giving an overall pregnancy and neonatal loss rate of 14/34 (41.1%). <b><i>Conclusion:</i></b> The risk of foetal loss in prenatally diagnosed T21 is high at 38% with an overall pregnancy loss rate of 41.1%. This information may be of benefit when counselling couples who are faced with a diagnosis of T21 particularly in the context of limited access to TOP.

Investigation of the lawsuits regarding down syndrome

“…In the same article, the miscarriage rate in the control group was 1.23% and the authors concluded that the procedure related risks of miscarriage following amniocentesis and CVS are lower than expected. In a study by O'Connor et al, 11.7% of mothers of a fetus with Down syndrome and who continued their pregnancy had miscarriage and 26.4% had stillbirth [9]. If these types of invasive methods are performed by expert teams, the miscarriage rate is very low and maternal death was not reported in the literature.…”